Product Information
ESLICARBAZEPINE 200 MG TABLET is a generic product labeled by Lupin Pharmaceuticals Inc., priced at $2.0565 per EA under NDC 68180029006. Its NADAC has been published 45 times since Aug 20, 2025.
Strength
200 mg/1
Manufacturer
Lupin Pharmaceuticals Inc.NDC
68180029006
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
ESLICARBAZEPINE ACETATEApproval Type
Generic (ANDA)
FDA Application
ANDA211246On Market Since
5/6/2025
Pharmacological Classes
Price Statistics
The NADAC for ESLICARBAZEPINE 200 MG TABLET has been published 45 times since Aug 20, 2025, and over the history we have for it it has declined 45.3%. The table below summarizes its recorded NADAC range and movement.
| Current price | $2.0565 per EA |
|---|---|
| All-time high | $3.9207 (Apr 15, 2026) |
| All-time low | $2.0565 (Jun 17, 2026) |
| 52-week high | $3.9207 |
| 52-week low | $2.0565 |
| Median price | $3.4621 |
| Average price | $3.4130 |
| Largest weekly change | -25.0% (May 20, 2026) |
| Weeks tracked | 45 |
| Tracking since | Aug 20, 2025 |
Generic Alternatives
The matcher finds 3 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 3 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of ESLICARBAZEPINE 200 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for ESLICARBAZEPINE 200 MG TABLET, manufactured by Lupin Pharmaceuticals Inc., is $2.0565 per EA (NDC 68180029006), effective Jun 24, 2026.
How has the price of ESLICARBAZEPINE 200 MG TABLET changed over time?
Over the history we have for it, the NADAC for ESLICARBAZEPINE 200 MG TABLET has declined 45.3%. It has been tracked across 45 weekly CMS publications since Aug 20, 2025.
What are the highest and lowest recorded NADAC prices for ESLICARBAZEPINE 200 MG TABLET?
Since Aug 20, 2025, the NADAC for ESLICARBAZEPINE 200 MG TABLET has ranged from a low of $2.0565 (Jun 17, 2026) to a high of $3.9207 (Apr 15, 2026), with a median of $3.4621 per EA.
Are there cheaper alternatives to ESLICARBAZEPINE 200 MG TABLET?
3 NADAC-published products share the same active ingredient, strength, and dosage form as ESLICARBAZEPINE 200 MG TABLET, but none are currently priced below it.
Who manufactures ESLICARBAZEPINE 200 MG TABLET?
ESLICARBAZEPINE 200 MG TABLET (NDC 68180029006) is labeled by Lupin Pharmaceuticals Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification